Teladoc extends post-Q4 selloff as analysts point to outlook

Teladoc (NYSE:TDOC) extended post-market losses on Thursday after the telehealth provider announced mixed earnings results for Q4, prompting analysts to focus on the company’s underwhelming outlook.

While the Purchase, New York-based firm’s revenue for Q4 at $640.5M exceeded the consensus despite a ~3% YoY